| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 11 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 2 | TACROLIMUS OINTMENT 0.1% | 11 |
| 3 | AGALSIDASE BETA | 6 |
| 4 | ALGLUCOSIDASE ALFA | 4 |
| 5 | MYCOPHENOLATE MOFETIL | 3 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 7 | ADALIMUMAB | 2 |
| 8 | IDURSULFASE | 2 |
| 9 | ACETAMINOPHEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALGLUCOSIDASE ALFA | 4 | 0.0016 |
| 1 | AGALSIDASE BETA | 6 | 0.0006 |
| 2 | IDURSULFASE | 2 | 0.0005 |
| 3 | LARONIDASE | 1 | 0.0002 |
| 4 | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0.0002 |
| 5 | ETODOLAC | 1 | 0.0002 |
| 6 | VOCLOSPORIN | 1 | 0.0001 |
| 7 | TACROLIMUS OINTMENT 0.1% | 11 | 0.0001 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 | 0.0001 |
| 9 | GOLIMUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 4 | 0.0012 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 6 | 0.0006 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |